AKT1 and Familial prostate cancer: Our results showed that NC treatment decreased expression of ERK1/2 (Fig 4A) and AKT1 (Fig 4B) proteins in prostate cancer cells and AKT1 and HSP27 cells in MCF-7 cells (Fig 3A and 3B).